Idorsia Ltd
SIX:IDIA
Idorsia Ltd
Total Current Assets
Idorsia Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Current Assets
CHf223.8m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Current Assets
$306.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Current Assets
$2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
29%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Current Assets
CHf251.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Current Assets
CHf60.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Total Current Assets
CHf15.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
Glance View
Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
See Also
What is Idorsia Ltd's Total Current Assets?
Total Current Assets
223.8m
CHF
Based on the financial report for Dec 31, 2025, Idorsia Ltd's Total Current Assets amounts to 223.8m CHF.
What is Idorsia Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
-28%
Over the last year, the Total Current Assets growth was -12%. The average annual Total Current Assets growth rates for Idorsia Ltd have been -28% over the past three years .
